Cabaletta Bio files $240M mixed securities shelf

* Cabaletta Bio (NASDAQ:CABA [https://seekingalpha.com/symbol/CABA]) has filed [https://seekingalpha.com/filing/10277123]a registration statement with the SEC for a proposed $240M mixed securities offering.
* This registration statement contains a base prospectus that covers the sale of common stock, preferred stock, debt securities, warrants and/or units in one or more offerings with a total value of up to $240M.
* It also contains a sales agreement prospectus covering the sale of up to $150M common stock that may be issued under a sales agreement entered into with TD Securities (USA [https://seekingalpha.com/symbol/USA]) LLC, or TD Cowen.

MORE ON CABALETTA BIO

* Cabaletta Bio: Sector Headwinds And Funding Issues, But Also Some Clear Clinical Direction [https://seekingalpha.com/article/4794063-cabaletta-headwinds-and-funding-issues-but-also-clear-clinical-direction]
* Cabaletta Bio announces pricing of public offering of securities; shares decline over 28% [https://seekingalpha.com/news/4457285-cabaletta-bio-announces-pricing-of-public-offering-of-securities-shares-decline-over-28]
* Cabaletta Bio slides on proposed securities offering [https://seekingalpha.com/news/4457141-cabaletta-bio-slides-on-proposed-securities-offering]
* Seeking Alpha’s Quant Rating on Cabaletta Bio [https://seekingalpha.com/symbol/CABA/ratings/quant-ratings]
* Historical earnings data for Cabaletta Bio [https://seekingalpha.com/symbol/CABA/earnings]